Patents by Inventor Giacomo Waller

Giacomo Waller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIP and VIP Agonists, Nanoparticles, and Uses in Inflammatory T-Cell Mediated Disease
    Publication number: 20240066101
    Abstract: In certain embodiments, this disclosure relates to VIP and VIP agonists, optionally conjugated to nanoparticles, for use in methods of treating inflammatory T cell-mediated diseases or conditions, e.g., treating or preventing GvHD. In certain embodiments, this disclosure relates to methods of pulmonary administration of VIP and VIP agonists, optionally conjugated to nanoparticles. In certain embodiments, this disclosure contemplates nanoparticles disclosed herein.
    Type: Application
    Filed: October 13, 2023
    Publication date: February 29, 2024
    Inventors: Giacomo Waller, Yiwen Li, Edmund Waller
  • VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease
    Patent number: 11786580
    Abstract: In certain embodiments, this disclosure relates to VIP and VIP agonists, optionally conjugated to nanoparticles, for use in methods of treating inflammatory T cell-mediated diseases or conditions, e.g., treating or preventing GvHD. In certain embodiments, this disclosure relates to methods of pulmonary administration of VIP and VIP agonists, optionally conjugated to nanoparticles. In certain embodiments, this disclosure contemplates nanoparticles disclosed herein.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: October 17, 2023
    Assignee: Emory University
    Inventors: Giacomo Waller, Yiwen Li, Edmund Waller
  • VIP and VIP Agonists, Nanoparticles, and Uses in Inflammatory T-Cell Mediated Disease
    Publication number: 20210187076
    Abstract: In certain embodiments, this disclosure relates to VIP and VIP agonists, optionally conjugated to nanoparticles, for use in methods of treating inflammatory T cell-mediated diseases or conditions, e.g., treating or preventing GvHD. In certain embodiments, this disclosure relates to methods of pulmonary administration of VIP and VIP agonists, optionally conjugated to nanoparticles. In certain embodiments, this disclosure contemplates nanoparticles disclosed herein.
    Type: Application
    Filed: April 23, 2019
    Publication date: June 24, 2021
    Inventors: Giacomo Waller, Yiwen Li, Edmund Waller
  • VIP Antagonists and Uses in Treating Cancer
    Publication number: 20210046152
    Abstract: This disclosure relates to methods of treating cancer or viral infections comprising administering an effective amount of a VIP antagonist in combination with an immune check-point inhibitor to a subject in need thereof. In certain embodiments, the immune check-point inhibitor is an anti-PD1 or anti-PDL1 antibody.
    Type: Application
    Filed: April 24, 2019
    Publication date: February 18, 2021
    Inventors: Edmund K. Waller, Yiwen Li, Giacomo Waller, Rebecca Pankove, Susan Thomas, Sruthi Ravindranathan